Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: Concerns

Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1111. doi: 10.31557/APJCP.2024.25.4.1111.NO ABSTRACTPMID:38679969 | DOI:10.31557/APJCP.2024.25.4.1111

Source: Asian Pacific Journal of Cancer Prevention - April 29, 2024 Category: Cancer & Oncology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research